Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2013 Mar 8;2013:bcr2012008509. doi: 10.1136/bcr-2012-008509

Subacute combined degeneration of the spinal cord following recreational nitrous oxide use

Hui Mei Cheng 1, Jae Hong Park 1, David Hernstadt 1
PMCID: PMC3618752  PMID: 23476009

Abstract

We describe a case of a young woman who developed myelopathy and peripheral neuropathy following 1 year of recreational nitrous oxide (N2O) use. She presented with uncomfortable tingling sensation in her feet and poor balance. Physical examination revealed mild weakness and hyper-reflexia in the lower limbs. Proprioception and vibration were absent in the lower limbs. Pinprick and light touch sensations were reduced below the sixth thoracic dermatome. A broad-based gait and a positive Romberg sign were noted. The level of vitamin B12 was low (76 pmol/l). T2-weighted MRI scans showed hyperintensity changes at the posterior column from the second to the fifth cervical vertebrae. She made a full recovery following injections of vitamin B12 and physiotherapy. This case discusses subacute combined degeneration of the spinal cord on a background of N2O abuse.

Background

Subacute combined degeneration of the spinal cord is a well-documented complication of vitamin B12 deficiency. However, nitrous oxide (N2O) toxicity as an aetiology of the condition is not well known. Recreational N2O use is prevalent among young people. This case highlights a potential rare complication of N2O toxicity and the importance of the consideration of N2O toxicity-induced subacute combined degeneration of the spinal cord as a possible diagnosis of a young patient with undifferentiated neurological symptoms.

Case presentation

A 22-year-old woman with no significant medical history presented with a gradual worsening of uncomfortable tingling sensation in her feet over 8 weeks and a 3-day history of poor balance. Upon further questioning, her social history was remarkable for recreational N2O bulb use. These are available at supermarkets for use in a dispenser for making whipped cream. First exposure was 1 year ago and since then she has been abusing N2O intermittently until approximately 2 months ago when she regularly used N2O approximately three times weekly with 60 bulbs per session. The patient reports good dietary intake and social alcohol use of no more than two standard drinks a day on average. There was no history of illicit drug use.

Upon examination, the patient was alert and oriented. Repeated voluntary movements of lower limbs were noted which patient reported improved paraesthesia. Cranial nerve and upper-limb neurological examinations were unremarkable. Lower-limb neurological examination revealed mild weakness (4-/5) and hyper-reflexia. Proprioception and vibration sensations were absent over the lower limbs. Pinprick and light touch sensations were reduced from below the sixth thoracic dermatome. A broad-based gait, positive Romberg and Lhermitte's signs were noted. Funduscopy revealed no optic atrophy.

Investigations

Blood tests show a low serum vitamin B12 level of 76 pmol/l (140–770 pmol/l). Anaemia was not detected and mean corpuscular volume was within the normal range. Methylmalonic acid level was raised at 0.92 (<0.35 µmol/l). Blood sugar level, thyroid function test, serum folate, copper and ceruloplasmin levels were normal. Antibodies to syphilis, Epstein-Barr virus, cytomegalovirus and HIV were negative. Intrinsic factor and parietal cell autoantibodies were absent. Swabs taken for gonorrhoea and chlamydia were all negative. T2-weighted MRI scans of the spinal cord showed subtle hyperintensity changes at the posterior column from the second to the fourth cervical vertebrae.

Cerebrospinal fluid analysis was not performed in this case because of the subacute presentation and a lack of risk factors for infectious causes.

Differential diagnosis

The clinical presentation is of symmetric subacute parasethesia, loss of propioception and progressive ataxic weakness that indicates posterior and lateral columns’ involvement. Differential diagnoses such as infectious (HIV-1 associated myelopathy, neurosyphilis), autoimmune (autoimmune myelopathy, Guillain-Barré syndrome), demyelinating (multiple sclerosis), nutritional (vitamin B12, copper deficiency) and neoplastic (paraneoplastic syndrome) disorders should be considered.

With investigations showing vitamin B12 deficiency and posterior column changes on MRI, subacute combined degeneration of the spinal cord was most likely. Common causes of vitamin B12 deficiency including pernicious anaemia, acquired malabsorption and malnutrition were ruled out with patient history and blood tests. The diagnosis of subacute combined degeneration of the spinal cord as a complication of N2O toxicity was made.

Treatment

The patient was admitted to the hospital under neurology for daily vitamin B12 injections (1000 µg/day) and physiotherapy.

Outcome and follow-up

She gradually improved and was discharged on day 13 with weekly injections of vitamin B12 (1000 µg/week) for 4 weeks. She was lost to follow-up postdischarge and repeat MRI could not be performed. She was reviewed incidentally at 18 months postdischarge and noted to be well and free of any disabling neurological symptoms.

Discussion

N2O is an inhalational anaesthetic agent commonly used in dentistry. Industrial applications include its uses as a food aerosol propellant and an engine accelerant.

N2O exerts its harmful effects by irreversibly oxidising the cobalt ion of cobalamin (vitamin B12). Oxidation of the cobalt ion by N2O inhibits methylcobalamin as a cofactor of methionine synthase in the production of methionine and subsequently S-adenosylmethionine, which is necessary for methylation of myelin sheath phospholipids.1 2 The result is demyelination of the nervous system involving the spinal cord and sometimes peripheral neuropathy and optic atrophy.3 Thus, N2O induces subacute combined degeneration through inactivation of the vitamin B12 metabolism. Pathological changes occur initially in the lower cervical and upper thoracic segments of the spinal cord which appear as high-signal lesions on T2-weighted MRI scans because of increased water content secondary to oedema.4 5 Clinically, patients with subacute combined degeneration may present with a subacute onset of paraparesis and impaired sensation and proprioception. The clinical diagnosis could be confirmed by an abnormal signal on MRI of the spinal cord, low-serum vitamin B12 levels and slowing of motor conduction velocities in peripheral nerve conduction studies. However, the findings of these tests could sometimes be normal.6 Measurement of methylmalonic acid levels can be employed to make the diagnosis in the presence of normal or low-normal vitamin B12 level.7

Abuse of N2O has been previously reported in the literature among healthcare workers, such as dentists, as well as young adults who use the drug more frequently.4 5 Despite its purportedly high-rate of usage, serious side-effects as a result of its abuse remain uncommon, with less than 20 cases reported in the literature.8–18 N2O use occurs among the younger population, with men more likely to have experimented with the drug and also more likely to present with neurological symptoms.15 The usual amount of N2O bulbs inhaled in a session is usually <5, but the average of bulbs inhaled among reported cases ranges from 10–20 to >100.8–18 This suggests that N2O use alone is unlikely to result in serious neurology among most young, healthy adults, but when used in excess of 10 bulbs/day, the risk of permanent neurological deficits, including ataxic paraplegia, increases exponentially. Among the reported cases, there appears to be a correlation between the amount of use and extent of symptoms although significant symptoms can occur with moderate use.8–18

Removal of the offending agent and vitamin B12 replacement appear to be an effective treatment. Whether the patient makes a partial or full recovery depends on the degree of the neuropathological damage to the spinal cord.18 The absence of sensory deficits and Romberg and Babinski signs were associated with a higher full recovery rate.18 In cases where symptoms persist methionine treatment has been successful where vitamin B12 treatment alone has failed.1 2

The incidence of N2O-induced neurotoxicity is underestimated and should be recognised as an important cause of subacute combined degeneration of the spinal cord especially in young patients presenting with undifferentiated neurological symptoms considering serious complications such as irreversible paralysis and cardiac arrest can occur, if not detected early.11

Learning points.

  • Nitrous oxide (N2O) abuse is not uncommon among young people.

  • N2O toxicity-induced subacute combined degeneration of the spinal cord should be considered as a possible diagnosis in a young patient with undifferentiated neurological symptoms.

  • Usage of more than 10 N2O bulbs/day has a potential to result in significant neurological complications.

  • Measurement of methylmalonic acid levels can be employed to make the diagnosis in the presence of normal or low-normal vitamin B12 level.

Footnotes

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Yagiela JA. Health hazards and nitrous oxide: a time for reappraisal. Anesth Prog 1991;38:1–11 [PMC free article] [PubMed] [Google Scholar]
  • 2.Louis-Ferdinand RT. Myeotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adverse Drug React Toxicol Rev 1994;13:193–206 [PubMed] [Google Scholar]
  • 3.Graber JJ, Sherman FT, Kaufmann H, et al. Vitamin B12-responsive severe leukoencephalopathy and autonomic dysfunction in a patient with “normal” serum B12 levels. J Neurol Neurosurg Psychiatry 2010;81:1369–71 [DOI] [PubMed] [Google Scholar]
  • 4.Layzer RB, Fishman RA, Schafer JA. Neuropathy following abuse of nitrous oxide. Neurol 1978;28:504–6 [DOI] [PubMed] [Google Scholar]
  • 5.Ilniczky J, Jelencsik I, Kenez J, et al. MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia—two cases. Eur J Neurol 2002;9:101–4 [DOI] [PubMed] [Google Scholar]
  • 6.Kumar N, Ahlskog JE, Klein CJ, et al. Imaging features of cupper deficiency myelopathy: a study of 25 cases. Neuroradiology 2006;48:78–83 [DOI] [PubMed] [Google Scholar]
  • 7.Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil 2005;86:150–3 [DOI] [PubMed] [Google Scholar]
  • 8.Wackawik A, Luzzio C, Juhasz-Poscine K, et al. Myelo-neuropathy from nitrous oxide abuse: unsually high methylmalonic acid and homocysteine level. Wis Med J 2003;102:43–5 [PubMed] [Google Scholar]
  • 9.Gillman MA. Nitrous oxide abuse in perspective. Clin Neuropharmacol 1992;15:297–306 [DOI] [PubMed] [Google Scholar]
  • 10.Ng J, O'Grady G, Pettit T, et al. Nitrous oxide use in first-year students at Auckland University. Lancet 2003;361:1349–50 [DOI] [PubMed] [Google Scholar]
  • 11.Cartner M, Sinnott M, Silburn P. Paralysis caused by “nagging”. Med J Aust 2007;187:366–7 [DOI] [PubMed] [Google Scholar]
  • 12.Alt RS, Morrissey RP, Gang MA, et al. Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J Emerg Med 2011;41:378–80 [DOI] [PubMed] [Google Scholar]
  • 13.Miller MA, Martinez V, McCarthy R, et al. Nitrous oxide “whippit” abuse presenting as clinical B12 deficiency and ataxia. Am J Emerg Med 2004;22:124. [DOI] [PubMed] [Google Scholar]
  • 14.Shulman RM, Geraghty TJ, Tadros M. A case of unusual substance abuse causing myeloneuropathy. Spinal Cord 2007;45:314–17 [DOI] [PubMed] [Google Scholar]
  • 15.Ng J, Frith R. Nanging. Lancet 2002;360:384. [DOI] [PubMed] [Google Scholar]
  • 16.Tatum WO, Bui DD, Grant EG, et al. Pseudo-guillain-barre syndrome due to “whippet”-induced myeloneuropathy. J Neuroimaging 2010;20:400–1 [DOI] [PubMed] [Google Scholar]
  • 17.Lin RJ, Chen HF, Chang YC, et al. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan 2011;20:129–37 [PubMed] [Google Scholar]
  • 18.Vasconcelos OM, Poehm EH, McCarter RJ, et al. Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med 2006;21:1063–8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES